Medifast trades below net cash, with an EV of -$43.68M, reflecting deep skepticism about its OPTAVIA MLM business and turnaround prospects. GLP-1 drugs have rendered MED's weight-loss model largely ...
The casual-dining chain will accelerate new openings in the coming years after finding strong demand for its retro, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results